Head Of Early Asset, Obu, International

AstraZeneca

Oncology asset strategy
Phase 2 through registration
International market archetypes
Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations

Job Summary

  • Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.
  • Own Oncology-specific iLVA policy, criteria, and templates; define explicit no-go thresholds and fast-track pathways to enable timely, data-driven decisions.
  • Lead the International Oncology Cross Functional Team (Commercial, Medical, Regulatory, Market Access/HEOR, Diagnostics, CMC/Supply, Finance, Digital); ensure clear accountabilities and delivery against iLVA and wave plan milestones.

Matching Summary

Lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.

Skills & Requirements

Must-have

  • Oncology asset strategy
  • Phase 2 through registration
  • International market archetypes
  • Evidence and access strategies
  • Cross-functional leadership
  • Companion diagnostics strategy

Nice-to-have

  • Entrepreneurial thinking
  • Adapt for local standards
  • Leveraging big data
  • Learning from colleagues

Key Requirements

  • Advanced scientific qualification (MD, PhD, or PharmD)
  • Deep Oncology expertise
  • Proven senior leadership
  • Strong command of clinical data interpretation
  • Demonstrated influence at senior governance
  • Exceptional analytical and strategic skills
  • Extensive matrix leadership

Work Rights

Not specified

Tailored Resume

Cover Letter